Peregrine Investment Management Inc. Makes New $6.08 Million Investment in Albemarle Corporation $ALB

Peregrine Investment Management Inc. purchased a new stake in Albemarle Corporation (NYSE:ALB) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 75,000 shares of the specialty chemicals company’s stock, valued at approximately $6,081,000. Albemarle makes up approximately 3.0% of Peregrine Investment Management Inc.’s investment portfolio, making the stock its 17th largest holding. Peregrine Investment Management Inc. owned approximately 0.06% of Albemarle at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Metis Global Partners LLC acquired a new stake in Albemarle in the 3rd quarter valued at approximately $217,000. Public Sector Pension Investment Board boosted its position in Albemarle by 4.6% during the 3rd quarter. Public Sector Pension Investment Board now owns 25,356 shares of the specialty chemicals company’s stock worth $2,056,000 after acquiring an additional 1,120 shares during the last quarter. Cibc World Market Inc. grew its stake in shares of Albemarle by 24.4% during the 3rd quarter. Cibc World Market Inc. now owns 38,476 shares of the specialty chemicals company’s stock worth $3,120,000 after acquiring an additional 7,542 shares in the last quarter. ING Groep NV raised its holdings in shares of Albemarle by 738.4% in the third quarter. ING Groep NV now owns 66,920 shares of the specialty chemicals company’s stock valued at $5,426,000 after purchasing an additional 58,938 shares during the last quarter. Finally, Impax Asset Management Group plc bought a new stake in shares of Albemarle in the third quarter worth $1,046,000. 92.87% of the stock is owned by institutional investors and hedge funds.

Albemarle News Roundup

Here are the key news stories impacting Albemarle this week:

• Positive Sentiment: Revenue beat and strong EV/energy-storage demand: Q4 revenue of $1.43B topped estimates and rose ~16% year-over-year, driven by higher Energy Storage volumes and favorable pricing — a sign that lithium end-market demand remains strong. Read More.
• Positive Sentiment: Analyst support and bullish research: Mizuho raised its price target to $185 (neutral rating) and Rothschild/Redburn published a bullish outlook — both actions underpin upside expectations from some sell-side desks. Read More. Read More.
• Positive Sentiment: Policy tailwind for domestic supply: The House passed H.R.3617 (Securing America’s Critical Minerals Supply Act), which aims to strengthen domestic critical-minerals supply chains — a structural tailwind for lithium producers like Albemarle. Read More.
• Neutral Sentiment: FY2026 revenue guidance lifted/updated: Albemarle provided a FY2026 revenue range of roughly $5.7B–$6.0B, above consensus — this signals management expects continued top-line resilience even if EPS guidance was unclear in early releases. Read More.
• Neutral Sentiment: Idling Kemerton Train 1 to preserve flexibility: Management moved Kemerton Train 1 to care & maintenance to improve financial flexibility and optimize global hydroxide mix — reduces near-term operating exposure but keeps restart optionality. Market sees this as prudent capacity management rather than a structural problem. Read More.
• Negative Sentiment: EPS miss and wider-than-expected quarterly loss: Albemarle reported Q4 EPS of ($0.53) vs. consensus ($0.40), which disappointed investors and weighed on near-term sentiment despite the revenue beat. Read More.
• Negative Sentiment: Immediate market reaction and technical pressure: Coverage and market commentary note the stock fell after earnings as traders booked gains and digested the EPS miss; technical indicators show short‑term momentum fatigue, adding to selling pressure. Read More. Read More.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Dbs Bank raised their target price on shares of Albemarle from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Friday, October 24th. Morgan Stanley restated an “equal weight” rating on shares of Albemarle in a research note on Friday, December 19th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Albemarle in a research report on Monday, December 29th. JPMorgan Chase & Co. upped their target price on Albemarle from $80.00 to $195.00 and gave the stock a “neutral” rating in a report on Wednesday, January 28th. Finally, Scotiabank raised Albemarle from a “sector perform” rating to a “sector outperform” rating and increased their price target for the company from $85.00 to $200.00 in a research report on Monday, January 12th. Three analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, eleven have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $163.40.

Albemarle Stock Down 9.7%

Shares of ALB stock opened at $158.47 on Friday. Albemarle Corporation has a 52-week low of $49.43 and a 52-week high of $195.68. The stock has a market cap of $18.65 billion, a price-to-earnings ratio of -27.56, a PEG ratio of 2.53 and a beta of 1.44. The firm’s 50-day moving average is $157.34 and its 200-day moving average is $114.39. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.51 and a current ratio of 2.27.

Albemarle (NYSE:ALB) last posted its quarterly earnings results on Wednesday, February 11th. The specialty chemicals company reported ($0.53) EPS for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.13). The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.34 billion. Albemarle had a positive return on equity of 0.40% and a negative net margin of 10.74%.The company’s revenue for the quarter was up 15.9% on a year-over-year basis. During the same quarter in the previous year, the business posted ($1.09) EPS. Sell-side analysts predict that Albemarle Corporation will post -0.04 EPS for the current year.

Albemarle Company Profile

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.